Citation
(2012), "Reviews of effectiveness", Clinical Governance: An International Journal, Vol. 17 No. 3. https://doi.org/10.1108/cgij.2012.24817caa.009
Publisher
:Emerald Group Publishing Limited
Copyright © 2012, Emerald Group Publishing Limited
Reviews of effectiveness
Glucagon-like peptide-1 receptor agonists on weight loss
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 17, Issue 3
Vilsboll, T., Christensen, M., Junker, A.E., Knop, F.K., Gluud, L.L.,Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials,BMJ,2012,Vol. 344,d7771
This well-conducted review concluded that treatment with glucagon-like peptide-1 receptor agonists led to weight loss in overweight or obese patients with or without type 2 diabetes. This conclusion is likely to be reliable for short-term treatment, although the evidence was stronger for people with diabetes than those without.